Adverum Biotechnologies (ADVM) Misses Q2 EPS by 89c

Adverum Biotechnologies (NASDAQ: ADVM) reported Q2 EPS of ($0.89).

For earnings history and earnings-related data on Adverum Biotechnologies (ADVM) click here.

You May Also Be Interested In

• Goldman Sachs Adjust Monthly US Director's Cut List
• UBS Assumes Interactive Brokers Group (IBKR) at Neutral, 'A Best-in-Class, Yet Fairly Valued Brokerage'
• Sphere Entertainment (SPHR) Reiterated at Market Outperform by Citizens: Global Expansion Apace